Magic mushroom drug psilocybin reduced depressive symptoms in trial
18 May 2016 | By Katie Sadler
A trial funded by the Medical Research Council has found psilocybin, the active ingredient in magic mushrooms, reduced depressive symptoms.
List view / Grid view
18 May 2016 | By Katie Sadler
A trial funded by the Medical Research Council has found psilocybin, the active ingredient in magic mushrooms, reduced depressive symptoms.
10 February 2016 | By Victoria White, Digital Content Producer, Drug Target Review
The MRC has launched a £1m rapid response funding initiative to better understand the nature of the risk posed by the Zika virus. Find out about this initiative and NIH's call for research here...
24 November 2015 | By Kate Douetil
UCL has announced the formation of Athena Vision, a biopharmaceutical company focused on developing gene therapies for eye diseases...
16 October 2015 | By Victoria White
The research raises the possibility that testing of those most at risk of the disorder could allow them to be treated early enough to avoid the disorder's most severe symptoms...
16 September 2015 | By Victoria White
A team at the International Centre for Genetic Engineering and Biotechnology (ICGEB) will join forces with MRC Technology to take on the project...
10 August 2015 | By Charlotte Batchelor, Drug Target Review
Twelve new treatments, diagnostics and medical technologies will receive funding from the eighth round of the successful Biomedical Catalyst (BMC)...
27 July 2015 | By Victoria White
The MRC and EPSRC have made a joint award of £16m to develop molecular pathology tests to help deliver stratified medicine in a wide range of disease areas...
21 July 2015 | By Victoria White
Medical Research Council (MRC) scientists have repaired a damaged liver in a mouse by transplanting liver stem cells grown in the laboratory...
15 July 2015 | By Victoria White
GSK and MRC are to collaborate on a unique open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases...